Impact of Partial Nephrectomy and Percutaneous Cryoablation on Short-term Health-related Quality of Life-A Prospective Comparative Cohort Study
- PMID: 36353658
- PMCID: PMC9637566
- DOI: 10.1016/j.euros.2022.09.013
Impact of Partial Nephrectomy and Percutaneous Cryoablation on Short-term Health-related Quality of Life-A Prospective Comparative Cohort Study
Abstract
Background: Partial nephrectomy (PN) is the gold standard for the treatment of stage cT1 renal cell carcinoma (RCC). However, the increasing incidence of RCC in the elderly population calls for alternative minimally invasive treatments to reduce the negative effects on patients' health-related quality of life (HRQoL) and subsequent healthy life expectancy.
Objective: To assess and compare short-term HRQoL and self-reported health status after PN and percutaneous cryoablation (PCA) of patients treated for RCC stage cT1.
Design setting and participants: Patients who underwent PN or PCA between 2019 and 2021 for RCC stage cT1 at two university hospitals in Denmark were assessed. The exclusion criteria included insufficient understanding of the Danish language, dementia, metastatic RCC, conversion to nephrectomy, and salvage procedures.
Intervention: PN and PCA.
Outcome measurements and statistical analysis: The European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire was distributed before treatment, and 14 and 90 d postoperatively. A linear mixed-effect model was used to analyze the changes from baseline to follow-up between PN and PCA treatment.
Results and limitations: The cohort included 165 patients (PN: 79; PCA: 86). The completion rate was 96-98%. Patients receiving PCA were significantly older (median 69.1 vs 62.1 yr) and had lower scores on physical (p < 0.001) and role functioning (p = 0.009) than PN. A statistically significant change from baseline to 14 d was found for several HRQoL scales, which favored PCA over PN. However, the observed change was no longer significant at 90-d follow-up. Limitations include sample size and confounding by indication.
Conclusions: This study found a significant difference between baseline and 14-d follow-up in several HRQoL and symptoms scales, favoring PCA over PN. However, no significant differences were observed in any HRQoL scales between PN and PCA of RCC stage cT1 from baseline to 90-d follow-up.
Patient summary: Surgical removal and percutaneous cryoablation (freezing) of small tumors in the kidney had a similar impact on quality of life after 90 d.
Keywords: Cryoablation; Health-related quality of life; Nephron-sparing treatment; Partial nephrectomy; Patient-reported outcome; Quality of life; Renal cell carcinoma.
© 2022 The Author(s).
Figures


Similar articles
-
Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis.Eur Urol. 2018 Feb;73(2):254-259. doi: 10.1016/j.eururo.2017.09.009. Epub 2017 Sep 28. Eur Urol. 2018. PMID: 28967553
-
Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.Eur Urol. 2019 Aug;76(2):244-251. doi: 10.1016/j.eururo.2019.04.026. Epub 2019 May 3. Eur Urol. 2019. PMID: 31060824
-
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.Eur Urol. 2015 Feb;67(2):252-9. doi: 10.1016/j.eururo.2014.07.021. Epub 2014 Aug 6. Eur Urol. 2015. PMID: 25108580
-
Clinical and Oncological Outcomes Following Percutaneous Cryoablation vs. Partial Nephrectomy for Clinical T1 Renal Tumours: Systematic Review and Meta-Analysis.Cancers (Basel). 2024 Mar 17;16(6):1175. doi: 10.3390/cancers16061175. Cancers (Basel). 2024. PMID: 38539509 Free PMC article. Review.
-
Cryoablation versus Partial Nephrectomy for Clinical Stage T1 Renal Masses: A Systematic Review and Meta-Analysis.J Cancer. 2019 Jan 29;10(5):1226-1236. doi: 10.7150/jca.28881. eCollection 2019. J Cancer. 2019. PMID: 30854132 Free PMC article. Review.
Cited by
-
Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis.World J Urol. 2024 Aug 7;42(1):474. doi: 10.1007/s00345-024-05172-1. World J Urol. 2024. PMID: 39112814 Free PMC article.
-
Cryoablation and Immunotherapy: An Enthralling Synergy for Cancer Treatment.Curr Oncol. 2023 May 8;30(5):4844-4860. doi: 10.3390/curroncol30050365. Curr Oncol. 2023. PMID: 37232823 Free PMC article.
-
Renal Function After CT-Guided Cryoablation of Small Renal Tumours in Patients with Solitary Kidney: An Analysis of European Multinational Prospective EuRECA Registry.Cardiovasc Intervent Radiol. 2024 May;47(5):583-589. doi: 10.1007/s00270-023-03634-4. Epub 2024 Jan 25. Cardiovasc Intervent Radiol. 2024. PMID: 38273129 Free PMC article.
References
-
- Ljungberg B, Albiges L, Bensalah K, et al. EAU guidelines on renal cell carcinoma. 2020. https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Renal-Cell-Carci....
-
- World Health Organization. Ageing and health. 2021. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health.
-
- Wang Y., Shao J., Lu Y., Li X. Thulium laser-assisted versus conventional laparoscopic partial nephrectomy for the small renal mass. Lasers Surg Med. 2019;52:402–407. - PubMed
-
- Watanabe H., Motoyama D., Sato R., et al. Health-related quality of life in patients with small renal mass who underwent robot-assisted partial nephrectomy: a prospective evaluation. J Endourol. 2021;35:1644–1649. - PubMed
LinkOut - more resources
Full Text Sources